Bluejay Diagnostics, Inc. Increase (Decrease) in Other Noncurrent Assets
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Other Noncurrent Assets of -$1.64 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-12
- Bluejay Diagnostics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$4.57K.
- Bluejay Diagnostics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $2.93K.
- Bluejay Diagnostics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$822.00, a 107.05% decline year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$13.44K.
- Bluejay Diagnostics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was -$27.35K, a 514.80% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $6.59K.
- Bluejay Diagnostics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$6.55K, a 146.14% decline from fiscal 2022.
- Bluejay Diagnostics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $14.19K, a 32.48% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$1.64K 10-Q · filed 2026-08-12 | -$2.47K derived: sum of 3 quarters · filed 2026-08-12 | -$15.90K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $2.93K 10-Q · filed 2026-05-07 | $2.10K derived: sum of 2 quarters · filed 2026-05-07 | -$11.33K derived: sum of 3 quarters · filed 2026-05-07 | -$23.60K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$822.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$14.26K derived: sum of 2 quarters · filed 2026-03-06 | -$26.53K derived: sum of 3 quarters · filed 2026-08-12 | -$27.35K 10-K · filed 2026-03-06 |
| 2025-09-30 | -$13.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$25.71K derived: sum of 2 quarters · filed 2026-08-12 | -$26.53K 10-Q · filed 2025-11-07 | -$14.87K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$12.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$13.09K 10-Q · filed 2026-08-12 | -$1.43K derived: sum of 3 quarters · filed 2026-08-12 | -$2.24K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$822.00 10-Q · filed 2026-05-07 | $10.84K derived: sum of 2 quarters · filed 2026-05-07 | $10.03K derived: sum of 3 quarters · filed 2026-05-07 | $9.22K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $11.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $10.85K derived: sum of 2 quarters · filed 2026-03-06 | $10.04K derived: sum of 3 quarters · filed 2026-03-06 | $6.59K 10-K · filed 2026-03-06 |
| 2024-09-30 | -$809.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$1.62K derived: sum of 2 quarters · filed 2025-11-07 | -$5.07K 10-Q · filed 2025-11-07 | -$6.31K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$808.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$4.26K 10-Q · filed 2025-08-07 | -$5.50K derived: sum of 3 quarters · filed 2025-08-07 | -$7.27K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$3.45K 10-Q · filed 2025-05-13 | -$4.69K derived: sum of 2 quarters · filed 2025-05-13 | -$6.46K derived: sum of 3 quarters · filed 2025-05-13 | -$8.23K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$1.24K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.01K derived: sum of 2 quarters · filed 2025-03-31 | -$4.78K derived: sum of 3 quarters · filed 2025-03-31 | -$6.55K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$1.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$3.54K derived: sum of 2 quarters · filed 2024-11-07 | -$5.30K 10-Q · filed 2024-11-07 | -$3.57K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$1.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$3.54K 10-Q · filed 2024-08-14 | -$1.80K derived: sum of 3 quarters · filed 2024-08-14 | -$3.40K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$1.77K 10-Q · filed 2024-05-15 | -$36.00 derived: sum of 2 quarters · filed 2024-05-15 | -$1.63K derived: sum of 3 quarters · filed 2024-05-15 | $13.21K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $1.73K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $136.00 derived: sum of 2 quarters · filed 2024-03-28 | $14.98K derived: sum of 3 quarters · filed 2024-03-28 | $14.19K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$1.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $13.25K derived: sum of 2 quarters · filed 2023-11-09 | $12.46K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $14.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $14.06K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$788.00 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $21.02K 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |